Clinical trials · Spokane, WA
Recurrent Endometrial Carcinoma clinical trials in Spokane
We’re tracking 5 recruiting recurrent endometrial carcinoma studies with a site in or near Spokane — including Phase 1/Phase 2, Phase 2 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies near Spokane
- NCT05377996RecruitingPhase 1/Phase 2
Study drug for advanced solid tumors with tumor tissue testing
This early-stage study tests emiltatug leda-dotin (Emi-Le) in people with advanced or recurring solid cancers. It aims to see how the drug works and how safely it can be given, using tumor tissue testing to help understand who may benefit.
Spokane, WashingtonAges 18 years+ - NCT05564377RecruitingPhase 2
Find targeted cancer treatments using genetic testing
This study matches people with advanced solid tumors to targeted treatment plans based on genetic testing. It also requires tumor sample testing to help doctors choose the most promising therapy for your specific tumor changes.
Post Falls, IdahoAges Any age - NCT05112601RecruitingPhase 2
Nivolumab plus or minus ipilimumab for dMMR endometrial cancer
This Phase 2 study tests the medicines nivolumab (with or without ipilimumab) in people with recurrent endometrial cancer that has “dMMR” (a specific tumor DNA repair defect). It aims to see whether this immune-based treatment can shrink tumors or help them stop growing.
Post Falls, IdahoAges 18 years+ - NCT07198074RecruitingPhase 3
Testing Avastin added to chemo plus Keytruda for certain endometrial cancer
This study tests adding Avastin (bevacizumab) to the standard combination of chemotherapy (carboplatin and paclitaxel) plus immunotherapy (Keytruda) for advanced or recurrent endometrial cancer with a specific genetic makeup (pMMR and TP53 mutation). The goal is to see if adding Avastin helps shrink tumors or slow their growth.
Post Falls, IdahoAges 18 years+ - NCT05256225RecruitingPhase 3
Adding Herceptin medicines to chemo for HER2-positive endometrial cancer
This Phase 3 trial tests whether adding Herceptin Hylecta or Phesgo to standard chemotherapy works better than chemotherapy alone for HER2-positive serous endometrial cancer or carcinosarcoma. It may help by improving how well treatment controls or shrinks the cancer.
Post Falls, IdahoAges 18 years+
Hear when a new Recurrent Endometrial Carcinoma trial opens near Spokane, WA
We’ll email you when one opens near Spokane, WA — at most once a week, no account needed, unsubscribe anytime.
Recurrent Endometrial Carcinoma trials in other cities
Where these studies are running near Spokane
Institutions with a site for the recruiting recurrent endometrial carcinoma studies listed above.
- Kootenai Clinic Cancer Services - Post Falls · 4 studies
- Kootenai Health - Coeur d'Alene · 4 studies
- Summit Cancer Centers
What taking part in a recurrent endometrial carcinoma study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting recurrent endometrial carcinoma studies in Washington.
Common questions
- Are there recurrent endometrial carcinoma clinical trials near Spokane?
- Yes. We're currently tracking 5 recruiting recurrent endometrial carcinoma studies with a site near Spokane, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a recurrent endometrial carcinoma study near Spokane?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Spokane to take part?
- Not necessarily. These studies have a site near Spokane, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a recurrent endometrial carcinoma trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New recurrent endometrial carcinoma studies open near Spokane regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.